Potential Therapeutic Strategies of Regenerative Medicine for Renal Failure.
BACKGROUND
Kidney diseases are a public health problem worldwide. Available therapies include function replacement by dialysis or transplant, which are associated with a high morbidity and mortality. Likewise, none of these treatments compensate all kidney functions. There is a great concern in developing more effective therapies with the ability to replace the wide range of renal functions, so that, new studies on developing therapeutic strategies have focused on regenerative medicine.


OBJECTIVE
The aim of this paper is to review the new advances in regenerative medicine for renal failure treatment.


RESULTS
Regenerative medicine comprises two therapeutic strategies: cell therapy and tissue engineering. Cell therapy techniques depend on cell and tissue cultures, with the aim to replace morphological structures, tissues, and functions. The main strategic strength of cell therapy in renal failure is the incorporation of additional cells in a damaged kidney, for which purpose different kind of Stem Cells (SCs) have been used such as Embryonic SCs, induced Pluripotent SCs, Multipotent SCs, Renal SCs, or drugs that increase survival and mobilization of SCs. Tissue engineering complements cell therapy combining techniques of biological sciences and engineering to create structures and devices as scaffolds, matrices or 3D biocompatible materials.


CONCLUSIONS
Even though there is a significant advance in regenerative medicine strategies, we are far from using any of its techniques on health institutions, due to it is necessary to evaluate side effects, biodistribution, dosage, type of administration, vehicle of cell therapy, as well as the evaluation of response time and long-term studies, among other studies.
Laboratorio de Biología Celular y Tisular, Escuela Medico Militar, Centro Militar de Ciencias de la Salud, Secretaría de la Defensa Nacional, Ciudad de Mexico, C.P. 11200, Mexico.|Centro de Investigacion en Biotecnología Aplicada, Instituto Politecnico Nacional, Tepetitla, Tlaxcala, 90700, Mexico.
Monica Maribel
MM
Mata-Miranda
Centro de Investigacion en Biotecnología Aplicada, Instituto Politecnico Nacional, Tepetitla, Tlaxcala, 90700, Mexico.
Raul Jacobo
RJ
Delgado-Macuil
Centro de Investigacion en Biotecnología Aplicada, Instituto Politecnico Nacional, Tepetitla, Tlaxcala, 90700, Mexico.
Marlon
M
Rojas-Lopez
Laboratorio de Biología Celular y Tisular, Escuela Medico Militar, Centro Militar de Ciencias de la Salud, Secretaría de la Defensa Nacional, Ciudad de Mexico, C.P. 11200, Mexico.
Ricardo
R
Martinez-Flores
Centro de Investigacion en Biotecnología Aplicada, Instituto Politecnico Nacional, Tepetitla, Tlaxcala, 90700, Mexico.|Laboratorio de Embriología, Escuela Medico Militar, Centro Militar de Ciencias de la Salud, Secretaría de la Defensa Nacional, Cerrada de Palomas S/N, Lomas de Sotelo, Miguel Hidalgo, Ciudad de Mexico, 11200, Mexico.
Gustavo Jesus
GJ
Vazquez-Zapien
D000818:Animals; D064987:Cell- and Tissue-Based Therapy / Q000379:methods*; D006801:Humans; D044968:Regenerative Medicine / Q000379:methods*; D051437:Renal Insufficiency / Q000628:therapy*; D023822:Tissue Engineering / Q000379:methods
Renal failure; cell therapy; potential therapeutic strategies; regenerative medicine; tissue engineering